Drug Profile
Haemorrhagic fever with renal syndrome vaccine - Liaoning ChengDa Biotechnology
Alternative Names: HFRS vaccine - ChengdaLatest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator Liaoning ChengDa Biotechnology
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Viral haemorrhagic fevers
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Viral-haemorrhagic-fevers in China (IM, Injection)